Biofrontera Inc.
BFRI
Rang in Aktien
#31614
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization... Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Aktienkurs
$0.8066
Zuletzt synchronisiert: 2026-10-20
Marktkapitalisierung
$11.98M
Veränderung (1 Tag)
0.11%
Veränderung (1 Jahr)
-72.66%
Land
US
Handel Biofrontera Inc. (BFRI)
Kategorie
Healthcare
Kursverlauf für Biofrontera Inc. (BFRI)
Höchster Schlusskurs: $2.93 am 2024-06-01
Niedrigster Schlusskurs: $328.16 am 2006-10-01
Niedrigster Schlusskurs: $328.16 am 2006-10-01
Kursverlauf der Aktie von Biofrontera Inc. von 2006 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2024 | -73.04% |
| 2023 | -68.52% |
| 2022 | -5.85% |
| 2021 | -48.56% |
| 2020 | -30.24% |
| 2019 | -15.14% |
| 2018 | 34.15% |
| 2017 | 41.58% |
| 2016 | 70.60% |
| 2015 | -31.22% |
| 2014 | -36.74% |
| 2013 | -4.76% |
| 2012 | 28.04% |
| 2011 | 56.02% |
| 2010 | -25.62% |
| 2009 | 48.88% |
| 2008 | -87.41% |
| 2007 | -3.58% |
| 2006 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $62.21 | 65.98% |
US
|
|
| $50.49 | 50.82% |
SE
|
|
| $180.41 | 37.52% |
FR
|
|
| $62.81 | 5.96% |
IT
|
|
| $116.87 | 55.01% |
US
|
